Pharmananogene Research Group

• del Pozo-Rodríguez A, Delgado D, Solinís MA, Pedraz JL, Echevarría E, Rodríguez JM, Gascón AR.  Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration International Journal of Pharmaceutics,  2010;  385,  157 - 162
• Ochoa L, Igartua M, Hernández RM, Solinís MA, Gascón AR, Pedraz JL.  In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: Level A in vitro–in vivo correlation European Journal of Pharmaceutics and Biopharmaceutics,  2010;  75,  232 - 237
• Zuñiga L, Calvo B.  Biosimilars: pharmacovigilance and risk management Pharmacoepidemiology and Drug Safety,  2010;  19,  661 - 669
• Zuñiga L, Calvo B.  Biosimilars approval process Regulatory Toxicology and Pharmacology,  2010;  56
• Calvo B, Zuñiga L.  Regulatory basis of biosimilar medicinal products: Need for harmonization Pharmaceuticals Policy and Law,  2010;  12,  205 - 215
• Calvo B, Zuñiga L.  Medicamentos biotecnológicos: Biosimilares. Requisitos exigidos para su desarrollo y aprobación Información Tecnológica,  2010;  21,  125 - 132